US approves Emergent's smallpox vaccine for people at high risk of mpox

A test tube labelled "Mpox virus positive" is held in this illustration taken August 20, 2024. — Reuters In a bid to deal with mpox infection, the US Food and Drug Administration approved expanded use of Emergent BioSolutions' EBS.N ACAM2000 smallpox vaccine to include people at high...

from The News International - Health https://ift.tt/r9KDBoX